Thomas John C 4

What Happened

John C. Thomas, a director of Dogwood Therapeutics, was granted 16,800 shares as a derivative award on June 16, 2026. The Form 4 shows the award was acquired at a $0.00 price (transaction code A), indicating a compensatory grant (likely restricted stock units or a similar equity award) rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-16; Form 4 filed: 2026-06-17 (timely filing).
• Grant amount and price: 16,800 shares at $0.00 (derivative award).
• Shares owned after transaction: not specified in the provided filing details.
• Transaction code: A = Award/Grant (compensatory); no 10b5-1, tax-withholding, or cashless-sale notes were reported in the summary provided.
• Filing timeliness: reported the next day — not marked late.

Context

This was a compensatory equity grant to a director, common for board compensation and typically subject to vesting or other transfer restrictions. It is not a market purchase or sale and does not, by itself, indicate immediate buying or selling of stock.